Form 8-K - Current report:
SEC Accession No. 0001104659-25-059336
Filing Date
2025-06-13
Accepted
2025-06-13 16:02:45
Documents
12
Period of Report
2025-06-13
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518002d1_8k.htm   iXBRL 8-K 26138
  Complete submission text file 0001104659-25-059336.txt   191368

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20250613.xsd EX-101.SCH 3023
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20250613_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20250613_pre.xml EX-101.PRE 22364
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2518002d1_8k_htm.xml XML 3679
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 251046356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)